with frontal lobe degeneration of the non-Alzheimer's type.
J Neurochem 69: 2005–2010.
Bond A, Lader M (1974). The use of analogue scales in rating
subjective feelings. Br J Med Psychol 47: 211–218.
Chatterjee A, Fahn S (2002). Methylphenidate treats apathy
in Parkinson's disease. J Neuropsychiatry Clin Neurosci 14:
461–462.
Clark L, Cools R, Robbins TW (2004). The neuropsychology of
ventral prefrontal cortex: decision-making and reversal learning.
Brain Cogn 55: 41–53.
Clark L, Manes F, Antoun N, Sahakian BJ, Robbins TW (2003). The
contributions of lesion laterality and lesion volume to decisionmaking deficits following frontal lobe damage. Neuropsychologia
41: 1474–1483.
Clarke HF, Dalley JW, Crofts HS, Robbins TW, Roberts AC (2004).
Cognitive inflexibility after prefrontal serotonin depletion.
Science 304: 878–880.
Conners C, Eisenberg L (1963). The effects of methylphenidate on
symptomatology and learning in disturbed children. Am J
Psychiatry 120: 458–464.
Cools R, Barker RA, Sahakian BJ, Robbins TW (2003). L-Dopa
medication remediates cognitive inflexibility, but increases
impulsivity in patients with Parkinson's disease. Neuropsychologia 41: 1431–1441.
Coull JT, Sahakian BJ, Hodges JR (1996). The alpha(2) antagonist
idazoxan remediates certain attentional and executive dysfunction in patients with dementia of frontal type. Psychopharmacology 123: 239–249.
Crofts HS, Dalley JW, Collins P, Van Denderen JC, Everitt BJ,
Robbins TW et al (2001). Differential effects of 6-OHDA lesions
of the frontal cortex and the caudate nucleus on the ability to
acquire an attentional set. Cereb Cortex 11: 1015–1026.
Damasio AR (1996). The somatic marker hypothesis and the
possible functions of the prefrontal cortex. Philos Trans R Soc
London B 351: 1413–1420.
Deakin JB, Aitken MRF, Robbins TW, Sahakian BJ (2004b). Risktaking during decision-making in normal volunteers changes
with age. J Int Neuropsychol Soc 10: 590–598.
Deakin JB, Rahman S, Nestor PJ, Hodges JR, Sahakian BJ (2004a).
Paroxetine does not improve symptoms and impairs cognition
in frontotemporal dementia: a double-blind randomized controlled trial. Psychopharmacology 172: 400–408.
Diehl J, Grimmer T, Drzezga A, Riemenschneider M, Forstl H,
Kurz A (2004). Cerebral metabolic patterns at early stages of
frontotemporal dementia and semantic dementia. A PET study.
Neurobiol Aging 25: 1051–1056.
Elliott R, Sahakian BJ, Matthews K, Bannerjea A, Rimmer J,
Robbins TW (1997). Effects of methylphenidate on spatial
working memory and planning in healthy volunteers. Psychopharmacology 131: 196–206.
Ellsberg D (1961). Risk, ambiguity and the savage axioms. Q J Econ
75: 643–669.
Fallon JH, Koziell DA, Moore RY (1978). Catecholamine innervation of the basal forebrain II. Amygdala, suprarhinal cortex and
entorhinal cortex. J Comp Neurol 180: 501–532.
Folstein MF, Folstein SE, McHugh PR (1975). Mini mental state: a
practical method of grading the cognitive state of patients for the
clinician. J Psychiatr Res 12: 189–198.
Francis PT, Holmes C, Webster MT, Stratmann GC, Procter AW,
Bowen DM (1993). Preliminary neurochemical findings in
non-Alzheimer dementia due to lobar atrophy. Dementia 4:
172–177.
Gilbert JJ, Kish SJ, Chang LJ, Morito C, Shannak K, Hornykiewicz
O (1988). Dementia, Parkinsonism, and motor neurone disease:
neurochemical and neuropathological correlates. Ann Neurol 24:
688–691.
Gilman AG, Goodman LS, Gilman A (eds) (1980). Pharmacological
Basis of Therapeutics. MacMillan: New York.
